Sign Up to like & get
recommendations!
0
Published in 2018 at "Current pharmaceutical design"
DOI: 10.2174/1381612824666181018153641
Abstract: BACKGROUND New Oral Anticoagulants (NOACs) are effective and widely used to prevent and treat thromboembolic diseases, but the response to NOACs differs according to ABCB1 genotypes. OBJECTIVE We investigated the effects of ABCB1 genotypes on…
read more here.
Keywords:
pharmacokinetics clinical;
clinical outcomes;
review;
abcb1 genotypes ... See more keywords